|Product name||Biotinylated Recombinant Human BCMA Protein|
|Description||Biotinylated Recombinant Human BCMA Protein is produced by Expi293 expression system. The target protein is expressed with sequence (Met1-Ala54 Trimer ) of Human BCMA fused with a His tag and Avi at the C-terminal.|
|Bio-Activity||Immobilized Biotinylated Human BCMA, His Tag at 0.5ug/ml (100ul/Well). Dose response curve for Anti-Human BCMA Ab.with the EC50 of 5.9ng/ml determined by ELISA.|
|Purity||> 95% by Tris-Bis PAGE;> 95% by SEC-HPLC|
|Endotoxin||< 1 EU/μg of the protein by LAL method.|
|Formulation||Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4.|
|Synonym||CD269 antigen; CD269; TNFRSF17; B cell maturation antigen; B-cell maturation protein; BCMA; BCMA tumor necrosis factor receptor superfamily member 17; BCMB-cell maturation factor; tumor necrosis factor receptor superfamily; member 17|
|Storage||Store the lyophilized protein at -20°C to -80°C for long term.|
After reconstitution, the protein solution is stable at -20°C for 3 months, at 2-8°C for up to 1 week.
|Reconstitution||Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water.|
Submit your question about RP02287 below and we will get back to you within one business day.
Alternatively, call us at 888.754.5670.